epigallocatechin gallate has been researched along with folic acid in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| García-Cánovas, F; Navarro-Martínez, MD; Rodríguez-López, JN | 1 |
| Ashrafi, A; Moinfar, N; Rahimi, M | 1 |
| Cabezas-Herrera, J; Chazarra, S; Otón, F; Rodríguez-López, JN; Sánchez-del-Campo, L; Tárraga, A | 1 |
| Inoue, M; Koh, WP; Robien, K; Van Den Berg, DJ; Wang, R; Yu, MC | 1 |
| Cabezas-Herrera, J; García-Cánovas, F; Navarro-Perán, E; Rodríguez-López, JN; Sánchez-Del-Campo, L | 1 |
| Jiang, R; Yuan, S; Zhang, XN; Zhang, Y; Zhao, XH; Zu, YG | 1 |
| Green, KN; Hendrix, C; LaFerla, FM; Parachikova, A | 1 |
| Jin, XF; Liu, Q; Ran, ZH; Tong, JL; Xiao, SD; Xu, Q; Xu, XT; Yang, CH | 1 |
| Furumiya, M; Hayashi, Y; Inaoka, E; Inoue, K; Nishijima, C; Ohta, K; Yamashiro, T; Yuasa, H | 1 |
| Itoh, T; Kissei, M; Narawa, T | 1 |
| Chang, JB; Ho, CT; Liu, JJ; Liu, TZ; Shang, HS | 1 |
| Chiba, T; Sato, Y; Sekine, Y; Sonoda, M; Umegaki, K | 1 |
| Chaves, LL; Granja, A; Neves, AR; Nunes, C; Pinheiro, M; Reis, S; Vieira, AC | 1 |
| Fan, Y; Hou, H; Li, B; Yang, H; Yang, T | 1 |
| Chatterjee Debnath, M; Ganguly, S; Jha, T; Kazi, J; Sen, R | 1 |
| Agudelo, NA; Echeverri-Cuartas, CE; Gartner, C | 1 |
| Al-Hendy, A; Christman, GM; Flaminia, A; Flores, VA; González, F; Huang, H; Johnson, JJ; Segars, J; Siblini, H; Singh, B; Taylor, HS; Zhang, H | 1 |
| Frega, A; Fuso, A; Gentili, C; Lepore, E; Proietti, S; Unfer, V | 1 |
1 trial(s) available for epigallocatechin gallate and folic acid
| Article | Year |
|---|---|
Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women.
Topics: Adult; Catechin; Clomiphene; Female; Folic Acid; Humans; Infertility; Leiomyoma; Letrozole; Liver; Prospective Studies; Tea | 2023 |
17 other study(ies) available for epigallocatechin gallate and folic acid
| Article | Year |
|---|---|
Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis; Catechin; Drug Synergism; Enzyme Inhibitors; Ergosterol; Folic Acid; Folic Acid Antagonists; Fungal Proteins; Leucovorin; Microbial Sensitivity Tests; Models, Biological; Naphthalenes; S-Adenosylmethionine; Spectrum Analysis; Terbinafine; Tetrahydrofolate Dehydrogenase; Vitamin B Complex | 2006 |
The potential benefits of green tea in patients with uveitis.
Topics: Anti-Inflammatory Agents; Antioxidants; Catechin; Clinical Trials as Topic; Folic Acid; Humans; Immunosuppressive Agents; Inflammation; Methotrexate; Models, Biological; Models, Theoretical; Tea; Uveitis | 2007 |
Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate.
Topics: Antioxidants; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Folic Acid; Folic Acid Antagonists; Gene Expression Profiling; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Models, Molecular; Molecular Structure; NADP; RNA, Messenger; Stereoisomerism; Structure-Activity Relationship; Tea; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Time Factors | 2008 |
Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study.
Topics: Aged; Breast Neoplasms; Case-Control Studies; Catechin; Female; Folic Acid; Folic Acid Antagonists; Genotype; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Risk Factors; Tea; Thymidylate Synthase | 2008 |
The anti-inflammatory and anti-cancer properties of epigallocatechin-3-gallate are mediated by folate cycle disruption, adenosine release and NF-kappaB suppression.
Topics: Adenosine; Anticarcinogenic Agents; Antioxidants; Caco-2 Cells; Catechin; Colonic Neoplasms; Folic Acid; Humans; I-kappa B Proteins; Leucovorin; NF-kappa B; NF-KappaB Inhibitor alpha; Proto-Oncogene Proteins c-akt; Tumor Necrosis Factor-alpha; Vitamin B Complex | 2008 |
[Preparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticles].
Topics: Antineoplastic Agents, Phytogenic; Catechin; Cell Death; Cell Line, Tumor; Drug Carriers; Drug Compounding; Drug Delivery Systems; Folic Acid; Humans; Male; Nanoparticles; Particle Size; Prostatic Neoplasms; Serum Albumin, Bovine | 2009 |
Formulation of a medical food cocktail for Alzheimer's disease: beneficial effects on cognition and neuropathology in a mouse model of the disease.
Topics: Acetylcysteine; Alkaloids; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Ascorbic Acid; Benzodioxoles; Brain; Catechin; Cerebral Cortex; Cognition; Curcumin; Dietary Supplements; Folic Acid; Hippocampus; Humans; Immunoblotting; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Transgenic; Piperidines; Polyunsaturated Alkamides; Thioctic Acid; Vitamin B Complex; Vitamins | 2010 |
Chemopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced gastrointestinal cancer in rat model.
Topics: Adenocarcinoma; Administration, Oral; Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Folic Acid; Gastrointestinal Neoplasms; Hematinics; Male; Methylnitronitrosoguanidine; Rats; Rats, Wistar; Sarcoma; Treatment Outcome | 2011 |
Noncompetitive inhibition of proton-coupled folate transporter by myricetin.
Topics: Animals; Biological Transport; Catechin; Cell Line; Dogs; Flavonoids; Folic Acid; Folic Acid Antagonists; Humans; Methotrexate; Proton-Coupled Folate Transporter | 2014 |
Effect of epigallocatechin gallate on drug transport mediated by the proton-coupled folate transporter.
Topics: Caco-2 Cells; Catechin; Cells, Cultured; Folic Acid; HEK293 Cells; Humans; Methotrexate; Proton-Coupled Folate Transporter | 2014 |
Folate deficiency-triggered redox pathways confer drug resistance in hepatocellular carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Folic Acid; Heat-Shock Proteins; Hep G2 Cells; Humans; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Oxidation-Reduction; Reactive Oxygen Species; RNA Interference; Signal Transduction; Survivin | 2015 |
Effect of Tea Catechins on Folate Analysis in Green Tea by Microbiological Assay.
Topics: alpha-Amylases; Aspergillus oryzae; Catechin; Enzyme Inhibitors; Folic Acid; gamma-Glutamyl Hydrolase; Lactobacillus acidophilus; Peptide Hydrolases; Streptomyces griseus; Tea | 2016 |
Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate.
Topics: Catechin; Drug Carriers; Folic Acid; Humans; Lipids; Nanostructures | 2017 |
Interactions of quercetin, curcumin, epigallocatechin gallate and folic acid with gelatin.
Topics: Binding Sites; Catechin; Circular Dichroism; Curcumin; Folic Acid; Gelatin; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Protein Binding; Protein Structure, Secondary; Quercetin; Spectrometry, Fluorescence; Thermodynamics | 2018 |
Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Liberation; Drug Stability; Female; Folic Acid; Half-Life; Humans; Male; MCF-7 Cells; Mice; Mice, Nude; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Surface Properties; Technetium | 2020 |
Chitosan-PEG-folate-Fe(III) complexes as nanocarriers of epigallocatechin-3-gallate.
Topics: Catechin; Chitosan; Delayed-Action Preparations; Drug Compounding; Drug Stability; Ferric Compounds; Folic Acid; Nanoparticles; Particle Size; Polyethylene Glycols; Surface Properties | 2020 |
Epigallocatechin gallate, folic acid, vitamin B12, and hyaluronic acid significantly increase apoptosis and p53 expression in HeLa cells.
Topics: Apoptosis; Female; Folic Acid; HeLa Cells; Humans; Hyaluronic Acid; Papillomavirus Infections; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms; Vitamin B 12 | 2023 |